Lantheus Holdings (LNTH) Cash from Investing Activities Growth (3y) (2017 - 2026)
Lantheus Holdings (LNTH) Cash from Investing Activities Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | 8.16% |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | 26.15% |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | 75.05% |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | - |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | 33.33% |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | -129.09% |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | -2.94% |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | - |
| 10 | Lantheus Holdings | 78.78 Mn | -419.80 Mn | 230.92 Mn | 37.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.22% |
| Dec 31, 2025 | 64.84% |
| Sep 30, 2025 | -274.34% |
| Jun 30, 2025 | -276.87% |
| Mar 31, 2025 | -257.89% |
| Dec 31, 2024 | -13.26% |
| Sep 30, 2024 | -203.72% |
| Jun 30, 2024 | -157.00% |
| Mar 31, 2024 | -115.50% |
| Dec 31, 2023 | -47.19% |
| Sep 30, 2023 | 189.55% |
| Jun 30, 2023 | -80.70% |
| Mar 31, 2023 | -154.57% |
| Dec 31, 2022 | -282.22% |
| Sep 30, 2022 | -22.22% |
| Jun 30, 2022 | -8.14% |
| Mar 31, 2022 | 49.12% |
| Dec 31, 2021 | 14.87% |
| Sep 30, 2021 | 21.51% |
| Jun 30, 2021 | 22.13% |